Liraglutide
Liraglutide
Also known as: Saxenda, Victoza, NN2211
Overview
Key Facts
Primary Goal: Research and therapeutic applications of Liraglutide
Activates GLP-1 receptors to reduce appetite and caloric intake. Slows gastric emptying for prolonged satiety.
Dosing Information
~13 hours
0.6–3 mg
Once daily
Ongoing / indefinite under medical supervision
Benefits
- Clinically meaningful weight loss (5-10% body weight)
- Improved glycemic control
- Reduced cardiovascular event risk (LEADER trial)
- Extensive long-term safety data
- Approved for adolescents aged 12+
Side Effects
Mechanism of Action
Activates GLP-1 receptors to reduce appetite and caloric intake
Slows gastric emptying for prolonged satiety
Enhances insulin secretion in a glucose-dependent manner
Contraindications
Do not use this peptide if any of the following apply:
- Personal or family history of medullary thyroid carcinoma
- MEN2 syndrome
- History of pancreatitis
- Pregnancy or breastfeeding
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
The SCALE trial programme demonstrated that liraglutide 3.0 mg daily produces an average weight loss of approximately 8% over 56 weeks. The LEADER cardiovascular outcomes trial showed a 13% reduction in MACE events. One of the earliest GLP-1 agents approved for weight management, with over a decade of post-marketing safety data.
Frequently Asked Questions
Common questions about Liraglutide
UK-Specific Information
Exclusive data points and guidance for UK residents using Liraglutide
UK Lab Testing
UK Lab Testing
Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.
Share on TikTok
Generate a trackable link to share this peptide information on TikTok